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Hydrogen sulfide (H2S) is an important biological signaling molecule that has been
recognized alongside nitric oxide and carbon monoxide as being a small gasotransmitter
that is enzymatically produced and impacts multiple physiological functions. To detect
hydrogen sulfide, there has been a focus on developing fluorescent probes to target
particular analytes; however, fluorescent probes lack sensitivity and depth penetration due
to background autofluorescence and light scattering. Chemiluminescence does not require
light excitation, which greatly reduces the amount of autofluorescence and photoactivation.
In order to detect hydrogen sulfide in living systems with high sensitivity, a series
of sterically stabilized 1,2-dioxetane chemiluminescent reduction-reaction based hydrogen
sulfide probes have been synthesized. These probes are prepared in 10-11 synthetic steps,
with key transformations including a Horner-Wadsworth-Emmons reaction to form a tetrasubstituted enol ether, a Mitsunobu reaction to install the sensing trigger, and a versatile
Heck reaction to append electron-withdrawing groups. The final preparation of the
sterically crowded 1,2-dioxetane proceeds in high yields and is accomplished by a [2+2]
cycloaddition with singlet oxygen generated by an energy pooling mechanism from triplet
iv

oxygen and the triplet state of methylene blue accessed via visible light irradiation. The
appendage of an acetoxymethyl ester enables cell-trappability and enhances utility for
monitoring hydrogen sulfide in living cells. These newly synthesized hydrogen sulfide
chemiluminescent probes have been tested at a physiological relevant pH both in vitro and
in living systems.
This dissertation contains the synthesis and characterization of two new hydrogen
sulfide chemiluminescent probes, CHS-4 and CHS-5-AM.
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Chapter 1
Chemiluminescent Hydrogen Sulfide Probes
1.1 Introduction
1.1.1 Introduction to Chemiluminescence

Figure 1. A. The Jablonski diagram depicting the photophysical process of fluorescence.
B. Potential energy surface for a chemiluminescent reaction. (1)
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The Jablonski diagram depicts three energy surfaces and highlights significant
photophysical processes. Although the diagram simplifies the energy surfaces, each energy
surface is a combination of all a molecules vibrational modes and possible interconversions
between chemical structures. The y-axis denotes potential energy, while Morse potentials
are at different locations along the x-axis.
Photochemistry starts at the ground state (S0), and when a single molecule is
exposed to light with an appropriate amount of energy, the molecule can be absorbed to
the excited electronic state (S1). Then relaxation occurs, which is radiationless conversion
of the vibrational excited states to the ground vibrational state of S1. From the ground
vibrational state of S1, conversion back to S0 can occur with the emission of a photon
known as fluorescence. If the excited state is accessed through a chemical reaction, then
the emission of the photon is called chemiluminescence (Figure 1, B). If the conversion
from S1 to S0 occurs without emitting a photon and heat is released instead, this is known
as internal conversion. The third way to exit from S1 is through intersystem crossing. This
consists of the interconversion of different spin states to form the triplet excited state (T1)
without the release of a photon. Then, radiationless vibrational relaxation can occur to
convert the excited states to the ground vibrational state of T1. The transition from the
triplet-excited state to the ground singlet state with the emission of a photon is known as
phosphorescence (1) (Figure 1, A).
Unlike fluorescence, the excited state for a chemiluminescent reaction is not
accessed through light absorption. A chemiluminescent thermal reaction begins by
progressing upwards towards the transition state. Then near the transition state, the ground
2

state and the excited state are close enough in energy that essentially allows the system to
hop over into the excited state. The reaction proceeds forward to the minimum of the
excited state surface, and the product is produced there in the excited state. Lastly, the
product relaxes down to the ground state with the emission of a photon (1)
(Figure 1, B).

1.1.2 Biological Roles of Hydrogen Sulfide
Hydrogen sulfide is commonly known as a toxic gas with a rotten egg odor and
environmental pollutant, but in recent years hydrogen sulfide has been discovered to be an
important biological signaling molecule and plays various roles in mammalian physiology.
Hydrogen sulfide has joined nitric oxide (NO) and carbon monoxide (CO) as the third
biological gasotransmitter. A gasotransmitter is a small gas molecule that is enzymatically
produced and influences numerous physiological functions (2,3,4). For example, hydrogen
sulfide plays a role in vasorelaxation (5), angiogenesis (6), neuromodulation (7), diabetes
(8), and cancer (9). Understanding the biological role of H2S is much more difficult
compared to NO and CO due to its redox activity and nucleophilic properties. (10) In order
to understand hydrogen sulfide signaling and deepen our knowledge to the impact it has,
hydrogen sulfide detection tools are being developed.
The pKa of hydrogen sulfide is 7.0 making it a weak acid. The pKa of the
deprotonated form (HS-) is greater than 14, and under physiological conditions HS- makes
up about 80% of the speciation (2). The high nucleophilicity of HS- allows for this gaseous
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molecule to react with electrophilic functional groups on reactive nitrogen, oxygen, and
sulfur species.

1.1.3 Enzymatic Production of Hydrogen Sulfide
The enzymatic production pathways of hydrogen sulfide involve three main
enzymes: cystathionine γ-lyase (CSE), cystathionine β-synthase (CBS), and 3mercaptopyruvate sulfurtransferase (3-MST)/ cysteine aminotransferase (CAT) (2). Both
CBS and CSE use vitamin B6 as a cofactor, and each pathway uses either L-cysteine or
homocysteine to obtain the sulfur atom for hydrogen sulfide.
CBS can catalyze the production of hydrogen sulfide in the presence of L-cysteine.
Additionally, CBS catalyzes the formation of cystathionine with homocysteine and the
cofactor vitamin B6 (Figure 2). Each CBS subunit has 551 amino acids (11). The NH2
terminal of CBS has binding cites for the cofactor pyridoxal-phosphate (PLP) and heme
(12). The heme group plays a redox sensor role and PLP is the active form of vitamin B6
and functions as the catalytic domain (13). The COOH terminal of CBS has a regulatory
domain of about 140 residues (2). When this regulatory domain is deleted, CBS is activated
(14). CBS expression is primarily found in the brain, and when the regulatory domain has
mutations this can lead to an array of diseases (15,16).
Once CBS has catalyzed the production of cystathionine, CSE can generate the
production of hydrogen sulfide and release ammonia and α-ketobutyrate (Figure 2). CSE
is also capable of yielding hydrogen sulfide from L-cysteine, while also producing
ammonia and pyruvate. Furthermore, CSE can generate hydrogen sulfide by first
4

catalyzing L-cystine to produce thiocysteine, which can lead to the production of hydrogen
sulfide with the use of CSE. Human deficiency of CSE can lead to metabolic disorders and
increased risk of developing bladder cancer (17).
The last enzymatic hydrogen sulfide production pathway uses both CAT and MST.
First, CAT converts L-cysteine to 3-mercaptopyruvate (Figure 2). Then MST uses 3mercaptopyruvate to transfer the sulfur to sulfite or an available sulfur acceptor. The direct
product of this production pathway is sulfane sulfur not hydrogen sulfide. To obtain
hydrogen sulfide, atomic sulfur would need to be reduced or hydrogen sulfide could be
released from thiosulfate or persulfides (18, 19,20). MST is found in the kidney, liver,
heart, and brain, and defects with MST have not shown any disorders (21, 22).

Figure 2. Enzymatic hydrogen sulfide production pathways in mammalian cells. CBS,
cystathionine β-synthase; CSE, cystathionine γ-lyase; CAT, cysteine aminotransferase;
MST, 3-mercaptopyruvate sulfurtransferase.
5

When studying the production of hydrogen sulfide in vivo, experiments can be done
using small-molecule inhibitors to modify the amount of hydrogen sulfide produced. For
example, propargylglycine (PAG) is a common CSE inhibitor that is used to decrease the
synthesis of hydrogen sulfide (23, 24). Opposite of inhibitors, enzymatic stimulators can
be utilized to increase the release of hydrogen sulfide. A commonly used allosteric
activator of CBS is S-adenosylmethionine (adoMet), which stimulates the production of
more hydrogen sulfide (25, 26).

1.1.4 Current Methods to Detect Hydrogen Sulfide

Scheme 1. A. Methylene blue (MB) and B. monobromobimane (mBB) hydrogen sulfide
quantification methods.

The most common hydrogen sulfide quantification methods currently used are the
methylene blue (MB) assay and monobromobimane (mBB), which both require the sample
to be homogeneous. These methods work for samples such as blood or serum but not for
heterogeneous samples such as cells or living tissue. The methylene blue assay is a
6

commonly used method that uses iron (III) chloride catalyzed electrophilic aromatic
substitution for hydrogen sulfide detection (Scheme 1, A). The product has a characteristic
absorbance at 670 nm that allows for quantification (27). Drawbacks from this method
include a limit of detection of only 2 μM, which makes it difficult to differentiate between
sulfur species (28). Additionally, highly acidic conditions are needed, which can lead to
sulfur extraction from other biological resources and decrease the accuracy (27). Another
commonly used hydrogen sulfide quantification method is monobromobimane (Scheme 1,
B). This process involves the reaction between two equivalents of mBB and one equivalent
of hydrogen sulfide. Due to mBB reacting with both hydrogen sulfide and thiols,
fluorescence HPLC is needed for separation and quantification (28). Although this method
has a limit of detection as low as 2 nM, it cannot be used for cellular or tissue culture
experiments (28). Overall, methylene blue and monobromobimane are useful tools to
detect hydrogen sulfide, but different detection methods need to be investigated to expand
the realm of biological hydrogen sulfide detection.

7

Scheme 2. Common reaction-based detection strategies for hydrogen sulfide fluorescent
and chemiluminescent scaffolds including A. reduction, B. nucleophilic attack, and C.
metal precipitation.
8

Another hydrogen sulfide detection method is the application of

reaction-based

luminescent probes. Similar to the methylene blue assay and the monobromobimane
method, hydrogen sulfide detection relies on the product after hydrogen sulfide reacts with
the probe. Although this time the product is light. This offers much greater spatiotemporal
data and allows for live cell and tissue imaging experiments. The reaction-based
luminescent probe detection strategy requires a hydrogen sulfide reactive site that triggers
light emission (Scheme 2). These hydrogen sulfide triggers can be categorized into three
main groups: reduction, nucleophilic, and metal precipitation. The most commonly used
detection strategy is azide reduction due to the selectivity over other reactive sulfur,
oxygen, and nitrogen species (29). Additionally, numerous hydrogen sulfide triggers have
been made utilizing the nucleophilicity of HS-. This strategy requires hydrogen sulfide to
attack an electrophilic functional group on the probe leading to the removal of the caging
protecting group (29). Furthermore, metal precipitation can be used to detect hydrogen
sulfide. For example, when a metal ion such as Cu2+ is ligated to a fluorescent molecule,
the fluorescence is quenched. Then in the presence of hydrogen sulfide, CuS precipitates
out and triggers the turn-on response from the fluorescent probe (30). Overall, reactionbased luminescent detection offers greater spatiotemporal data and allows for cellular and
live tissue experiments.

9

Figure 3. All current chemiluminescent hydrogen sulfide probes.

In just the past two years, over one hundred hydrogen sulfide detecting fluorescent
probes have been synthesized. This number emphasizes the importance and need of having
a sensitive and selective spatiotemporal hydrogen sulfide detecting device. On the other
hand, only five chemiluminescent hydrogen sulfide probes have ever been reported (31,
32) (Figure 3). Chemiluminescence compared to fluorescence does not require light
excitation. This notably reduces the background autofluorescence and photoactivation of
azide functional groups. In 2013, the Pluth group published the first chemiluminescent
hydrogen sulfide probe, which has a luminol azide structure (31). In the presence of
hydrogen sulfide, the azide gets reduced to the amine and then subsequently reacts with
H2O2 / HRP (horseradish peroxidase) to generate chemiluminescence. Then in 2015, the
Lippert group published the first generation of chemiluminescent hydrogen sulfide probes
based off of the chemically induced electron exchange luminescence (CIEEL) mechanism
(32). Overall, chemiluminescent hydrogen sulfide probes are still in the beginning stages
of development with much room for improvement in areas such as sensitivity, selectivity,
and cell permeability.

10

1.1.5 Design of CHS-4 and CHS-5

hv

Scheme 3. Design strategy for hydrogen sulfide chemiluminescent probe CHS-4 and CHS5-AM.

This design strategy for developing highly sensitive, cell permeable
chemiluminescent hydrogen sulfide probes consists of a scaffold with three main parts: a
hydrogen sulfide specific protecting group, an electron withdrawing group, and a stable
1,2- dioxetane (33) (Scheme 3). The purpose of the protecting group is to provide high
selectivity for hydrogen sulfide against other reactive nitrogen, oxygen, or sulfur species.
The hydrogen sulfide trigger chosen for probes CHS-4 and CHS-5-AM was the azideprotecting group due to its selectivity and the strong reduction property of hydrogen
sulfide. An electron-withdrawing group was added to the scaffold at the conjugated
position to the phenolate to create a donor-acceptor pair to increase the final light emission.
Lastly, the 1,2-dioxetane that is stabilized by the adamantane group plays an important role
the chemically induced electron exchange luminescence (CIEEL) mechanism.

11

Figure 4. Chemiluminescent hydrogen sulfide probes CHS-4 and CHS-5-AM.
The final structure for CHS-4 and CHS-5-AM include an acrylonitrile and
acetoxymethyl ester electron-withdrawing group, respectively (Figure 4). The
acetoxymethyl ester makes the CHS-5-AM scaffold cell permeable, and intracellular
esterase cleaves the acetoxymethyl ester once the probe is inside the cell in the cytoplasm.
The addition of this particular functional group allows for cellular testing to be conducted
without the need of a fluorescent enhancer. Furthermore, the chlorine substituent on both
CHS-4 and CHS-5-AM reduces the pKa of the phenolate and improves the phenolate’s
relative concentration (32). This results in the rate of chemiluminescent decomposition to
be increased at a physiological pH.

Scheme 4. Mechanism of hydrogen sulfide detection for CHS-5-AM.

The mechanism of hydrogen sulfide detection begins with reduction of the azideprotecting group by hydrogen sulfide and is followed by self-immolative cleavage to yield
the phenolate bearing the 1,2-dioxetane. The free phenolate will emit light spontaneously

12

after decomposition through the chemically induced electron exchange luminescence
(CIEEL) mechanism. (Scheme 4)

Scheme 5. Mechanism for the reduction of the azide-protecting group by hydrogen
sulfide.

The mechanism for the reduction of an azide-protecting group by hydrogen sulfide
was recently investigated in 2015 by the Pluth group (34) (Scheme 5). The first step in the
reduction of the azide-protecting group is the reversible attack on the terminal nitrogen of
the azide by HS-. The terminal nitrogen is the most electrophilic, and this nucleophilic
attack is modeled in the Staudinger reaction mechanism as well (35). This yields an anionic
azidothiol intermediate, which is then protonated to give a neutral compound. Next, the
attack of a second equivalent of HS- results in the formation of N2, H2S2, and a deprotonated
amine. The last step in the mechanism is a proton transfer reaction yielding the final amine.

13

Scheme 6. Chemically Induced Electron Exchange Luminescence (CIEEL) mechanism
through A. direct chemiexcitation and B. chemiexcitation by the Back Electron Transfer
(BET) process.

The Chemically Induced Electron Exchange Luminescence (CIEEL) mechanism
results in light emission through electron transfer and describes the general
chemiluminescent process. A practical CIEEL system consists of a dioxetane that is
thermally stabilized by spiroadamantane with a protected phenolate ion. The mechanism
begins with the removal of the protecting group by a certain analyte trigger to release the
phenolate ion. Next, intramolecular electron transfer occurs between the phenolate ion and
the O–O bond. This step is the rate-limiting step due to the energy needed to remove one
14

electron from the phenolate ion and transfer it to the peroxide bond (36). From here, the
mechanism can precede either directly or through Back Electron Transfer (BET), although
research favors the mechanism that utilizes BET (37). This mechanism occurs in a solvent
cage between two radical molecules, which is dependent on the solvent viscosity. An
increase in chemiexcitation is observed with an increase in solvent viscosity (38). The final
step in the mechanism leads to light emission from the excited methyl m-oxybenzoate
relaxing down to the ground state. (Scheme 6)

15

1.2 Results and Discussion
1.2.1 Synthesis of Chemiluminescent Hydrogen Sulfide Probes CHS-4 and CHS-5

Scheme 7. Synthesis of CHS-5-AM.
16

The synthesis of CHS-5-AM began with 2-chloro-3-methoxybenzaldehyde being
treated with trimethyl orthoformate in the presence of p-toluenesulfonic acid in methanol
to yield the acetal compound 2. This acetal was then treated with triethyl phosphite and
boron trifluoride diethyl etherate in DCM to give the diethyl methoxy phosphonate
compound 3. Next, a Horner–Wadsworth–Emmons reaction was conducted by the addition
of n-butyllithium and 2-adamantanone in THF to compound 3 to yield the enol ether
product compound 4. Then an SN2 reaction was performed on compound 4 by treating it
with sodium ethanethiolate and cesium carbonate in DMF. The resulting phenol product 5
is the leaving group of the SN2 reaction. Next, the phenol was treated with Niodosuccidimide in toluene to yield compound 6. Then a Heck reaction was conducted with
compound 6 by the addition of methyl acrylate, tri(o-tolyl)-phosphine, palladium (II)
acetate, and triethyl amine in acetonitrile to form a new carbon-carbon bond yielding
compound 7. Then compound 7 underwent a SN2 reaction attach to the hydrogen sulfide
trigger by the addition of compound 8 and potassium carbonate in acetone to yield
compound 9. Next, the ester group on compound 9 was subjected to hydrolysis upon the
addition of lithium hydroxide in THF to yield compound 10. Then bromomethyl acetate
and N,N-diisopropylethylamine were added to compound 10 in DCM to form the
acetoxymethyl ester functional group, compound 11. Finally, CHS-5-AM was obtained
through the formation of the 1,2-dioxetane by singlet oxygen by dissolving the scaffold in
DCM, adding the triplet sensitizer methylene blue hydrate, bubbling oxygen through, and
shining light. (Scheme 7)

17

Scheme 8. Synthesis of CHS-4.

The synthesis of CHS-4 is only three steps from compound 6. First, a Heck reaction
is conducted with compound 6, tri(o-tolyl)-phosphine, palladium (II) acetate, and triethyl
amine in acetonitrile to yield compound 12. Then the hydrogen sulfide azide trigger,
compound 13, is attached through a Mitsunobu reaction with the addition diethyl
azodicarboxylate and triphenylphosphine in THF to yield compound 14. Lastly, CHS-4 is
obtained through the use of singlet oxygen by dissolving compound 14 in DCM, adding
the triplet sensitizer methylene blue hydrate, bubbling oxygen through, and shining light.
(Scheme 8)

Scheme 9. Synthesis of the azide reagent.

18

To synthesize the hydrogen sulfide azide trigger reagents, 4-aminobenzyl alcohol
was first reacted with sodium nitrite and sodium azide in HCl to yield compound 13. Next,
compound 8 was obtained through the addition of p-toluenesulfonyl chloride, pyridine, and
sodium hydroxide in DCM to compound 13. (Scheme 9)
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Figure 5. Hydrogen sulfide dose dependence in vitro with Emerald II Enhancer. A.
Timescan for 20 μM CHS-5-AM, 1 mM Na2S, and various percentages of Emerald II
Enhancer (0, 0.2, 2, 10%) in PBS buffer (pH = 7.41). B. Timescan for 20 μM CHS-5-AM
with 0, 50, 100, 200, 400, 800, and 1000 μM Na2S with 2 % Emerald II Enhancer in PBS
buffer (pH = 7.41). Three replicates of each were performed on a F-7000 Hitachi
spectrophotometer.

The chemiluminescent response for CHS-5-AM was first tested using 20 μM CHS5-AM, various amounts of Emerald II Enhancer (0, 0.2, 2, 10%), and 1 mM Na2S. Twenty
minute timescans were ran at a physiologically relevant pH using PBS buffer (pH = 7.41)
with a F-7000 Hitachi spectrophotometer. Luminescence response appeared to increase
with increasing amounts of the Emerald II Enhancer. Furthermore, at least 0.2% Emerald
II Enhancer is necessary to see a response from 20 μM CHS-5-AM with 1 mM Na2S on
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this spectrophotometer (Figure 5, A). The chemiluminescent emission for CHS-5-AM was
then tested with increasing concentrations of Na2S holding the amount of enhancer constant
at 2%. Twenty minute time scans were conducted using 20 μM CHS-5-AM with 0, 50,
100, 200, 400, 800, and 1000 μM Na2S with 2% Emerald II Enhancer in PBS buffer (pH =
7.41). Instantaneous light emission was observed in a dose dependent manner under
physiological relevant conditions (Figure 5, B).
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Figure 6. Detection of hydrogen sulfide in A549 cells with Emerald II Enhancer. Nine
technical replicates across three biological replicates were performed using a Cytation 5
Bio Tek plate reader at 37 °C.

CHS-5-AM was tested in human lung adenocarcinoma epithelial (A549) to detect
endogenous hydrogen sulfide. CHS-5-AM was used due to its cell permeability from the
acetoxymethyl (AM) ester functional group. The cells were first incubated with 20 μM
CHS-5-AM for 30 minutes. Then the cells were washed with PBS to remove any
extracellular probe. Lastly, the cells were treated with Emerald II Enhancer (2, 2, 0, 0%)
and Na2S (1, 0, 1, 0 mM). The relative emission intensity was then recorded using a
Cytation 5 Bio Tek plate reader at 37 °C. The cells treated with enhancer produced
immediate light emission. The luminescence from the cells without addition of Na2S and
with enhancer could indicate that CHS-5-AM is detecting endogenous H2S. Furthermore,
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there was still observable light emission from the cells without the enhancer and treated
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Figure 7. Time scans of the chemiluminescent emission of A. 20 μM CHS-5-AM and B.
20 μM CHS-4 and 0, 50, 100, 200, 400, 800, 1000 μM Na2S in PBS buffer (pH = 7.41).
The integrated emission intensity of the chemiluminescent response for CHS-5-AM and
CHS-4 is depicted in C. and D. respectively. Three replicates of each were performed using
a Cytation 5 Bio Tek plate reader.

The response of CHS-5-AM and CHS-4 was then tested without the enhancer in
vitro with the Cytation 5 Bio Tek plate reader due to the noticeable sensitivity difference
compared to the F-7000 Hitachi spectrophotometer. 20 μM CHS-5-AM and CHS-4 were
treated with 0, 50, 100, 200, 400, 800, 1000 μM Na2S in PBS buffer (pH = 7.41). Both
CHS-5-AM and CHS-4 displayed instantaneous light emission in a dose dependent manner
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in biologically relevant conditions (Figure 7, A, B). There was a 4-fold and 2-fold increase
in integrated luminescence response from CHS-5-AM and CHS-4 respectively (Figure 7,
C, D).

1.2.3 Detection of Cellular Hydrogen Sulfide with CHS-5-AM
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Figure 8. A549 cellular response for 20 μM CHS-5-AM with 0, 500, and 1000 μM Na2S.
Nine technical replicates across three biological replicates were performed using a Cytation
5 Bio Tek plate reader at 37 °C.

Detection of endogenous hydrogen sulfide was then tested without enhancer with
CHS-5-AM. The cells were first incubated with 0, 500, and 1000 μM Na2S for 1 hour.
Then the cells were washed with PBS to remove any extracellular Na2S. Next, the cells
were treated with 20 μM CHS-5-AM and tested immediately with the plate reader at

37

°C. Two controls were used in this testing, one without any cells and one with cells. Both
controls only have 20 μM CHS-5-AM and no additional Na2S. An instantaneous
luminescence response was observed and maintained for 1 hour in a dose dependent
manner. The peak emission occurred around 15 minutes (Figure 8).
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Figure 9. Integrated emission intensity of the chemiluminescent response for A549 cells
treated with 20 μM CHS-5-AM and 0, 20, 200, 1000, and 2000 μM propargylglycine
(PAG). Additionally, there was a control without A549 cells, only containing 20 μM CHS5-AM and no addition of PAG. Seven technical replicates across four biological replicates
were performed using a Cytation 5 Bio Tek plate reader at 37 °C.

Propargylglycine (PAG) is a small molecule competitive inhibitor for the hydrogen
sulfide producing enzyme cystathionine γ-lyase (CSE). To examine the PAG inhibition of
endogenous hydrogen sulfide, A549 cells were incubated with 0, 20, 200, 1000, and 2000
μM PAG for 40 minutes in complete F-12K media at 37 °C with 5% CO2. Next, the cells
were washed with PBS, and then 20 μM CHS-5-AM was added. The Cytation 5 Bio Tek
plate reader recorded the relative emission intensity, and the integrated emission intensity
vs. the log of the concentration of PAG was observed (Figure 9).
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Figure 10. The MTT assay evaluating the cell viability of CHS-5-AM with 0, 0.1, 1, 10,
and 100 μM of CHS-5-AM after an 18-hour incubation period. Three technical replicates
across one biological replicate was performed using a Cytation 5 Bio Tek plate reader at
37 °C by Daphne Nguyen.

The 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay
was conducted using human lung adenocarcinoma epithelial cells (A549) that were
purchased from ATCC. The cells were first seeded into a 96-well plate giving a total
volume of 120 μL / well and maintained in an incubator at 37 °C with 5% CO2 for 12 hours.
Once about 80% cell confluence was achieved, the complete F-12K media was removed,
and the cells were washed with PBS. The cells were then treated with 0, 0.1, 1, 10, and 100
μM of CHS-5-AM and incubated for another 18 hours in 125 μL complete F-12K media
per well. Next, each well was treated with 10 μL of the MTT reagent (Cayman Chemical,
Ann Arbor, MI), mixed gently, and incubated for an additional 4 hours. Lastly, 100 μL of
crystal dissolving solution was added to each well to dissolve the formazan crystals. Then
the Cytation 5 Bio Tek plate reader was used to measure the absorbance at 570 nm and the
cell viability was reported as a percent of the control (Figure 10).
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1.3 Conclusions

To summarize, the next generation of hydrogen sulfide probes (CHS-4 and CHS5-AM) have been synthesized and characterized, expanding the general knowledge of
using chemiluminescence to detect hydrogen sulfide both in vitro and in vivo. CHS-4 and
CHS-5-AM produced instantaneous light emission in the presence of hydrogen sulfide in
a dose dependent manner in PBS buffer at a physiologically relevant pH. CHS-5-AM
proves the feasibility of developing chemiluminescent, cell-permeable probes that detect
endogenous hydrogen sulfide without the need of a fluorescent enhancer. Propargylglycine
(PAG) inhibition of cellular hydrogen sulfide production was also examined in living A549
cells with CHS-5-AM. Although improvement could be done on the scaffold design, CHS5-AM serves as a good building block to now increase sensitivity and kinetics in the next
generations of chemiluminescent hydrogen sulfide probes.

1.4 Experimental Methods
1.4.1 General Materials and Methods

All reactions were performed in dried glassware under an atmosphere of dry N2. Silica gel
P60 (SiliCycle) was used for column chromatography, and SiliCycle 60 F254 silica gel
(precoated sheets, 0.25 mm thick) was used for analytical thin layer chromatography. Plates
were visualized by fluorescence quenching under UV light or by staining with iodine.
Other reagents were purchased from Sigma-Aldrich (St. Louis, MO), Alfa Aesar (Ward
Hill, MA), EMD Millipore (Billerica, MA), Oakwood Chemical (West Columbia, SC), and
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Cayman Chemical (Ann Arbor, MI) and used without further purification. 1H NMR for
compounds 7,13, 14, and CHS-4 were collected on a Bruker 400 MHz spectrometer in the
Department of Chemistry at Southern Methodist University. 1H NMR for compound 2, 3,
4, 5, 6, 8, 9, 10, 11, CHS-5-AM and 13C NMR for compounds 9, 10, 11, and CHS-5-AM
were measured on a JEOL 500 MHz spectrometer in the Department of Chemistry at
Southern Methodist University. All 1H and 13C NMR spectra for characterization of new
compounds and monitoring reactions were collected in CDCl3 (Cambridge Isotope
Laboratories, Cambridge, MA). All chemical shifts are reported in the standard notation of
parts per million using the peak of residual proton signals of the deuterated solvent as an
internal reference. Coupling constant units are in Hertz (Hz). Splitting patterns are
indicated as follows: s, singlet; d, doublet; t, triplet; q, quartet; m, multiplet; dd, doublet of
doublets; dt, doublet of triplets.

2-chloro-1-(dimethoxymethyl)-3-methoxybenzene (2).
2-chloro-3-methoxybenzaldehyde (5 g, 29 mmol, 1.0 equiv.) was added to dry roundbottom flask, flushed with N2, and dissolved in 15 mL of anhydrous methanol. Ptoluenesulfonic acid (0.505 g, 2.93 mmol, 0.1 equiv.) and trimethyl orthoformate (3.2 mL,
29 mmol, 1 equiv.) were then added to the reaction mixture. The reaction was carried out
at room temperature and allowed to run for 24 hours under N2. After completion, the
reaction was transferred to a separatory funnel and washed with 30 mL NaHCO3. The
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organic layer was then eluted with 3 x 30 mL EtOAc. Subsequently, the organic layers
were combined and dried with Na2SO4, filtered, and concentrated under reduced pressure.
Column chromatography (10:1 hexanes: EtOAc) yielded compound (2) (5.181 g, 23.94
mmol, 82%) as a colorless oil. 1H NMR (500 MHz, CDCl3) δ 7.24 (s, 1H), 7.23 (s, 1H),
6.90 (d, 1H, J = 7 Hz ), 5.64 (s, 1H), 3.88 (s, 3H), 3.37 (s, 6H).

Diethyl ((2-chloro-3-methoxyphenyl)(methoxy)methyl)phosphonate (3). The acetal
compound (2) (6.409 g, 29.61 mmol, 1.00 equiv.) was added to an oven-dried roundbottom flask, flushed with N2, and dissolved in 10 mL anhydrous DCM. The reaction was
then cooled to 0 °C in an ice bath. Boron trifluoride diethyl etherate (3.83 mL, 30.5 mmol,
1.03 equiv.) was then added dropwise to the flask. Then triethyl phosphite (5.23 mL, 30.5
mmol, 1.03 equiv.) was added dropwise to the mixture, and the reaction was stirred for 10
minutes at 0 °C. The reaction mixture temperature was then raised to 35 °C in an oil bath
and stirred for 2 hours while being monitored by TLC. Upon completion, the reaction was
cooled to room temperature and quenched with 30 mL of NH4Cl. In a separatory funnel,
the organic layer was then eluted with 3 x 30 mL of EtOAc. Then the organic layers were
combined and dried with Na2SO4, filtered, and concentrated under reduced pressure.
Column chromatography (10:1 hexanes: EtOAc) yielded compound (3) (7.39 g, 22.9
mmol, 77 %) as a light brown oil. 1H NMR (500 MHz, CDCl3) δ 7.26 (s, 1H), 6.89 (s, 1H),
5.16 (d, 1H, J = 16 Hz), 4.14 – 3.88 (m, 5H), 3.88 (s, 3H), 3.32 (s, 3H), 2.01 (s, 1H).
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(1r,3r,5R,7S)-2-((2-chloro-3-methoxyphenyl)(methoxy)methylene)adamantine

(4).

Compound (3) (1.00 g, 3.09 mmol, 1.00 equiv.) was added to an oven-dried round-bottom
flask, flushed with N2, and dissolved in 10 mL anhydrous THF. The temperature was then
brought down to –78 °C in a dry-ice acetone bath. 2.5 M n-BuLi (1.50 mL, 3.72 mmol,
1.20 equiv.) was then added slowly and dropwise over 10 minutes. Next, 2-adamantanone
(0.577 g, 3.72 mmol, 1.20 equiv.) was dissolved in 5 mL anhydrous THF in a separate
round bottom flask and then added to the reaction mixture dropwise over 10 minutes. The
temperature is then raised to 35 °C in an oil bath and stirred for 2 hours. Subsequently, the
temperature was raised to 90 °C and put under reflux for 1 hour. Upon completion, the
reaction was cooled to room temperature and quenched with 30 mL of NH4Cl. The mixture
was transferred to a separatory funnel and the organic layer was eluted with 3 x 30 mL
EtOAc. The combined organic layers were then dried with Na2SO4, filtered, and
concentrated under reduced pressure. Column chromatography (20: 1 hexanes: EtOAc)
yielded compound (4) (0.683 g, 2.145 mmol, 69 %) as an amber oil. 1H NMR (500 MHz,
CDCl3) δ 7.19 (t, 1H, J = 16 Hz), 6.89 – 6.85 (m, 2H), 3.90 (s, 3H), 3.29 (s, 3H), 3.28 (s,
1H), 1.69 – 1.29 (m, 15H).
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3-(((1r,3r,5R,7S)-adamantan-2-ylidene)(methoxy)methyl)-2-chlorophenol (5). The
ether compound (4) (13.022 g, 40.897 mmol, 1.000 equiv.) was added to an oven-dried, N2
filled flask and dissolved in 70 mL of anhydrous DMF. Sodium ethanethiolate (4.128 g,
49.076 mmol, 1.200 equiv.) and cesium carbonate (33.31 g, 102.2 mmol, 2.50 equiv.) were
then added to the flask. The temperature was raised to 120 °C and stirred for 24 hours under
reflux. TLC was used to determine the completion of the reaction, and then the reaction
was quenched with 200 mL of NH4Cl. The reaction contents were transferred to a
separatory funnel, and the organic layer was eluted with 3 x 200 mL of EtOAc. Then the
organic layer was washed with 3 x 250 mL of brine. Lastly, the organic layers were
combined and dried with Na2SO4, filtered, and concentrated under reduced pressure.
Column chromatography (5:1 hexanes:EtOAc) was used for purification to give compound
(5) (10.557 g, 34.635 mmol, 85%) as an off-white solid. 1H NMR (500 MHz, CDCl3) δ
7.04 (t, 1H, J = 15 Hz), 6.91 (d, 1H, J = 6 Hz), 6.72 (d, 1H, J = 6 Hz), 3.22 (s, 3H), 3.19
(s, 1H), 2.01 – 1.84 (m, 16H).
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3-(((1r,3r,5R,7S)-adamantan-2-ylidene)(methoxy)methyl)-2-chloro-6-iodophenol (6).
Compound (5) (1.00g, 3.28 mmol, 1 equiv.) and N-iodosuccinimde (0.74 g, 3.3 mmol, 1.0
equiv.) were added to a round-bottom flask, flushed with N2, and then dissolved in 20 mL
of toluene. The reaction was carried out at 0 °C in an ice bath for 30 minutes. There is a
color change from light orange to red. Upon completion, the reaction mixture was
transferred to a separatory funnel and washed with brine. A couple of sodium thiosulfate
pentahydrate crystals were added to the separatory funnel to quench any remaining iodine.
Here there was a color change from red to clear after shaking the separatory funnel
containing the sodium thiosulfate pentahydrate crystals. If the color did not become clear,
more crystals were added. The organic layer was eluted with 3 x 30 mL of EtOAc. Then
the organic layers were combined, dried with Na2SO4, and concentrated under reduced
pressure. For purification, the crude product was rinsed multiple times with hexanes. A
solid white powder crashed out giving compound (6) (0.496 g, 1.151 mmol, 35%). 1H NMR
(500 MHz, CDCl3) δ 7.59 (d, 1H, J = 8 Hz), 6.60 (d, 1H, J = 8 Hz), 3.28 (s, 3H), 3.24 (s,
1H), 2.07 – 1.71 (m, 15H).
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Methyl (E)-3-(4-(((1r,3r,5R,7S)-adamantan-2-ylidene)(methoxy)methyl)-3-chloro-2hydroxyphenyl)acrylate (7). Compound (6) (0.123 g, 0.404 mmol, 1 equiv.), palladium
(II) acetate (0.004 g, 0.02 mmol, 0.05 equiv.), and tri(o-tolyl)-phosphine (0.001 g, 0.004
mmol, 0.01 equiv.) were added to an oven-dried pressure flask and flushed with N2. These
reagents were then dissolved in 5 mL of anhydrous ACN. Then methyl acrylate (0.11 mL,
1.2 mmol, 3 equiv.) and triethylamine (0.10 mL, 0.61 mmol, 1.5 equiv.) were added to the
pressure flask. The reaction was then tightly capped and heated to 120 °C for 2 hours. Upon
completion, the reaction was cooled to room temperature and quenched with 30 mL NH4Cl
and 30 mL of brine. The reaction contents were transferred to a separatory funnel, and the
organic layer was washed with 3 x 30 mL of EtOAc. Finally, the organic layers were
combined, filtered, and concentrated under reduced pressure. Column chromatography
(12:1 hexanes:EtOAc) yielded compound (7) (0.038 g, 0.098 mmol, 80%) as a brown oil.
1

H NMR (500 MHz, CDCl3) δ 7.97 (d, 1H, J = 16 Hz), 7.40 (d, 1H, J = 8 Hz), 6.88 (d, 1H,

J = 8 Hz), 6.63 (d, 1H, J = 16 Hz), 6.35 (s, 1H), 3.84 (s, 4H), 3.33 (s, 3H), 3.29 (s, 1H),
2.14 – 1.19 (m, 22H).
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4-azidobenzyl 4-methylbenzenesulfonate (8) Compound (13) (1.01 g, 6.79 mmol, 1.0
equiv.) was dissolved in 15 mL DCM in an oven-dried round bottom flask under N2
atmosphere and cooled to 0°C. p-Toluenesulfonic anhydride (3.323 g, 10.18 mmol, 1.5
equiv.) and pyridine (1.1 mL, 14 mmol, 2.0 equiv.) were added to the flask, stirred for 1
hour, and monitored by TLC. Upon completion, the crude reaction was washed with sat.
NH4Cl and brine, and eluted with 3 x 30 mL EtOAc. To purify, the crude product was
dissolved in 10 mL diethyl ether and filtered through a cotton plug. It was then dissolved
in 10 mL hexanes and cooled at 0°C for 1 hour. Then the supernatant was pipetted off and
washed with 2 x 10 mL hexanes. Finally, the pure product was concentrated under reduced
pressure yielding compound (8) (1.39 g, 4.58 mmol, 55%) and stored in the freezer. 1H
NMR (500 MHz, CDCl3) δ 7.72 (d, 2H, J = 9 Hz), 7.26 (d, 2H, J = 9 Hz), 7.17 (d, 2H, J =
9 Hz), 6.90 (d, 2H, J = 9 Hz), 4.95 (s, 2H), 2.38 (s, 3H).

Methyl(E)-3-(4-(((1r,3r,5R,7S)-adamantan-2-ylidene)(methoxy)methyl)-2-((4azidobenzyl)oxy)- 3-chlorophenyl)acrylate (9) The precursor phenol compound (7)
(0.0889g, 0.229 mmol, 1 equiv.) was added to an oven dried round bottom flask and
dissolved in 5 mL anhydrous DMF under N2 atmosphere. Compound (8) (0.0886 g, 0.292
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mmol, 1.5 equiv.) and K2CO3 (0.134 g, 0.970 mmol, 5 equiv.) were added and the reaction
was stirred at room temperature overnight and monitored with TLC. After completion, the
reaction was transferred to a separatory funnel and quenched with sat. NH4Cl. The organic
layer was eluted with 3 x 30 mL EtOAc, dried with Na2SO4, filtered, and concentrated
under reduced pressure. Column chromatography (25:1 hexanes: EtOAc) yielded
compound (9) (0.0204 g, 0.039 mmol, 20%) as an amber oil. 1H NMR (500 MHz, CDCl3)
δ 7.88 (d, 1H, J = 18 Hz), 7.44 (d, 2H, J = 8 Hz), 7.41 (d, 1H, J = 10 Hz), 7.06 (d, 1H, J =
8 Hz), 7.01 (d, 2H, J = 9 Hz), 6.42 (d, 1H, J = 16 Hz), 4.97 – 4.95 (m, 2H), 3.79 (s, 3H),
3.30 (s, 3H), 3.25 (s, 1H), 1.94 – 1.57 (m, 15H); 13C NMR (125 MHz, CDCl3) δ 167.18,
153.61, 140.44, 139.46, 138.89, 138.29, 132.75, 132.62, 130.59, 130.19, 129.9, 129.75,
127.96, 125.17, 119.99, 119.31, 119.20, 77.37, 77.12, 76.86, 57.37, 51.92, 39.29, 39.13,
38.74, 38.74, 38.68, 37.13, 33.02, 29.79, 28.43, 28.27.

(E)-3-(4-(((1r,3r,5R,7S)-adamantan-2-ylidene)(methoxy)methyl)-2-((4azidobenzyl)oxy)- 3-chlorophenyl)acrylic acid (10) Compound (9) (0.0204 g, 0.0392
mmol, 1 equiv.) was added to an oven dried round bottom flask and dissolved in 5 mL THF
under a N2 atmosphere. Then 5 mL of 1 M LiOH was added and the reaction was heated
to 80 °C under reflux for 5 hours and monitored with TLC. Upon completion, the reaction
was transferred to a separatory funnel and washed with 1 M HCl and eluted with 3 x 30

33

mL EtOAc. The organic layer was collected, dried with Na2SO4, filtered, and concentrated
under reduced pressure. Column chromatography (8:1 hexanes:EtOAc) yielded compound
(10) (0.0195 g, 0.385 mmol, 99%) as an amber oil. 1H NMR (500 MHz, CDCl3) δ 7.99 (d,
1H, J = 17 Hz), 7.45 – 7.47 (m, 3H), 7.10 (d, 1H, J = 9 Hz), 7.04 (d, 2H, J = 8 Hz), 6.44
(d, 1H, 16 Hz), 5.05 – 4.95 (m, 2H), 3.33 (s, 3H), 3.28 (s,1H), 2.01 – 1.60 (m, 15H); 13C
NMR (125 MHz, CDCl3) δ 171.96, 153.82, 141.10, 139.39, 138.78, 132.81, 132.61,
130.68, 129.98, 129.44, 128.02, 125.36, 119.34, 119.27, 77.38, 77.12, 76.87, 57.41, 39.29,
38.74, 37.12, 33.06, 29.81, 28.43, 28.28.

Acetoxymethyl(E)-3-(4-(((1r,3r,5R,7S)-adamantan-2-ylidene)(methoxy)methyl)-

2-

((4-azidobenzyl)oxy)- 3-chlorophenyl)acrylate (11). Compound (10) (0.02g, 0.04 mmol,
1 equiv.) was added to an oven dried round bottom flask and dissolved in 1 mL DMF under
a N2 atmosphere. Bromomethyl acetate ( 0.02 mL, 0.2 mmol, 4 equiv.) and DIPEA (0.024
mL, 0.14 mmol, 4 equiv.) were added, and the reaction stirred at room temperature for 4
hours while being monitored by TLC. Upon completion, the reaction was transferred to a
separatory funnel and quenched with sat. NH4Cl. The organic layer was eluted with 3 x 30
mL EtOAc, dried with Na2SO4, filtered, and concentrated under reduced pressure. Column
chromatography (5:1 hexanes: EtOAc) yielded compound (11) (0.02g, 0.035 mmol, 92%)
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as an amber oil. 1H NMR (500 MHz, CDCl3) δ 7.91 (d, 1H, J = 16 Hz), 7.39 – 7.35 (m,
3H), 7.02 (d, 1H, J = 10 Hz), 6.97 (d, 2H, J = 6 Hz), 6.36 (d, 1H, J = 14 Hz), 5.81 (s, 1H),
5.49 (s, 1H), 4.96 – 4.85 (m, 2H), 3.26 (s, 3H), 3.21 (s, 1H), 1.95 – 1.32 (m, 15H); 13C
NMR (125 MHz, CDCl3) δ 169.84, 165.25, 153.78, 140.75, 139.39, 138.83, 132.80,
132.55, 130.70, 129.97, 129.38, 128.01, 125.18, 119.27, 118.70, 77.38, 77.12, 76.87,
57.42, 39.28, 39.12, 38.73, 38.67, 37.11, 33.04, 29.80, 28.42, 28.26, 20.89.

acetoxymethyl(E)-3-(2-((4-azidobenzyl)oxy)-3-chloro-4-((1r,3r,5r,7r)-4'methoxyspiro[adamantane- 2,3'-[1,2]dioxetan]-4'-yl)phenyl)acrylate (CHS-5-AM)
Compound (11) (10 mg, 0.017 mmol, 1 equiv.) and methylene blue hydrate (4 mg, 0.01
mmol, 0.7 equiv.) were added to a dry flask and dissolved in 2 mL DCM. Oxygen was
bubbled through the reaction mixture, while irradiating with a 120 W light bulb (Home
Depot, Dallas, TX) at 0°C. After 1.5 hours, TLC indicated no starting material remained,
the reaction mixture was concentrated under reduced pressure. The product was purified
by column chromatography (4:1 hexanes:EtOAc) yielding compound (CHS-5-AM) (3.8
mg, 0.0064 mmol, 37%) as an amber oil. 1H NMR (500 MHz, CDCl3) δ 7.94 (d, 1H, J =
18 Hz), 7.55 (d, 1H, J = 12 Hz), 7.42 (d, 3H, J = 8 Hz), 7.03 (d, 3H, J = 8 Hz), 6.45 (d,
1H, J = 17 Hz), 5.86 (s, 3H), 4.89 (s, 3H), 3.21 (s, 3H), 2.99 (s, 1H), 0.83 – 2.02 (m, 15H);
C NMR (125 MHz, CDCl3) δ 169.79, 166.57, 164.98, 154.18, 140.72, 140.13, 135.81,
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132.23, 131.30, 130.76, 129.20, 127.93, 125.37, 119.97, 119.36, 111.79, 96.77, 96.44,
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77.37, 77.11, 76.86, 49.83, 36.65, 33.97, 33.68, 32.72, 32.29, 31.68, 31.64, 31.59, 29.79,
26.22, 25.90, 22.75, 20.87, 14.22.

(E)-3-(4-(((1r,3r,5R,7S)-adamantan-2-ylidene)(methoxy)methyl)-3-chloro-2hydroxyphenyl)acrylonitrile (12). Compound (6) (0.20 g, 0.46 mmol, 1.00 equiv.) and
palladium (II) acetate (0.011 g, 0.046 mmol, 0.10 equiv.) were added to an oven-dried
microwavable flask, flushed with N2, and dissolved in 1 mL of acetonitrile. Then
acrylonitrile (0.10 mL, 1.4 mmol, 3.0 equiv.) and triethylamine (0.10 mL, 0.70 mmol, 1.50
equiv.) were added to the reaction mixture. The flask was then capped and stirred in the
microwave for 70 minutes at 120 °C. Upon completion, the reaction was cooled to room
temperature and quenched with 15 mL of NH4Cl and transferred to a separatory funnel.
The organic layer was then eluted with 3 x 20 mL of EtOAc. The organic layers were then
combined, dried with Na2SO4, filtered, and concentrated under reduced pressure. Column
chromatography (9:1 hexanes: EtOAc) yielded compound (12) (0.069 g, 0.19 mmol, 42
%) as a brown oil. 1H NMR (500 MHz, CDCl3) δ 7.55 (d, 1H, J = 17 Hz), 7.25 (d, 1H, J =
8 Hz), 6.86 (d, 1H, J = 8 Hz), 6.32 (s, 1H), 6.15 (d, 1H, J = 17 Hz), 3.29 (s, 3H), 3.24 (s,
1H), 2.02 – 1.15 (m, 15H).
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(4-azidophenyl)methanol (13) 4-aminobenzyl alcohol (1.0 g, 8.1 mmol, 1.0 equiv) was
dissolved in 20 mL 10% HCl solution in a round bottom flask under N2 atmosphere and
cooled to 0°C. Sodium nitrite (0.672 g, 9.74 mmol, 1.2 equiv.) was dissolved in 10 mL
water, added slowly and dropwise, and allowed to stir for 30 min. Then sodium azide
(0.8278 g, 9.74 mmol, 1.2 equiv.) was dissolved in 10 mL water, added slowly and
dropwise, and stirred for an additional 2 hrs. The reaction was monitored by TLC. Upon
completion, the reaction was transferred into a separatory funnel, washed with brine, eluted
with 3 x 50 mL EtOAc. The combined organic layer was dried with Na2SO4, filtered, and
concentrated under reduced pressure. Purification by column chromatography (5:1
hexanes:EtOAc) yielded compound (13) (1.01 g, 6.79 mmol, 84%). 1H NMR (400 MHz,
CDCl3) δ 7.38 (d, 2H, J = 18 Hz), 7.02 (d, 2H, J = 18 Hz), 4.68 (s, 2H), 1.90 (s, 1H).

(E)-3-(4-(((1r,3r,5R,7S)-adamantan-2-ylidene)(methoxy)methyl)-2-((4azidobenzyl)oxy)- 3-chlorophenyl)acrylonitrile. (14) The precursor phenol, compound
(6) (0.035 g, 0.098 mmol, 1 equiv.) was dissolved in 3 mL anhydrous THF under a N2
atmosphere and cooled to 0°C. Compound (13) (0.0147 g, 0.098 mmol, 1 equiv.) and
triphenylphosphine (0.031 g, 0.12 mmol, 1.2 equiv.) were added to the reaction mixture
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and allowed to cool for 5 min. Then DEAD (0.02 mL, 0.1 mmol, 1.2 equiv.) was added
and stirred for 1 hr while being monitored by TLC. Upon completion, the reaction was
transferred to a separatory funnel and quenched with sat. NH4Cl. The organic layer was
eluted with 3 x 25 mL EtOAc, dried with Na2SO4, filtered, and concentrated under reduced
pressure. Column chromatography (8:1 hexanes:EtOAc) yielded compound (14) (5.2 mg,
0.01 mmol, 11%). 1H NMR (400 MHz, CDCl3) δ 7.54 (d, 1H, J = 16 Hz), 7.43 (d, 4H, J =
23 Hz), 7.33 (d, 2H, J = 23 Hz), 7.15 – 7.02 (m, 5H), 5.93 (d, 2H, J = 16 Hz), 5.43 (s, 1H),
5.01 (s, 3H), 4.54 – 4.53 (m, 2H), 3.35 (s, 3H), 3.31 (s, 1H), 2.19 – 0.91 (m, 21H).

(E)-3-(2-((4-azidobenzyl)oxy)-3-chloro-4-((1r,3r,5r,7r)-4'methoxyspiro[adamantane-2,3'- [1,2]dioxetan]-4'-yl)phenyl)acrylonitrile (CHS-4)
Compound (14) (5.2 mg, 0.01 mmol, 1 equiv.) and methylene blue hydrate (4 mg, 0.01
mmol, 0.7 equiv.) were added to a dry flask and dissolved in 2 mL DCM. Oxygen was
bubbled through the reaction mixture, while irradiating with a 120 W light bulb (Home
Depot, Dallas, TX) at 0°C. After 1.5 hours, TLC indicated no starting material remained,
the reaction mixture was concentrated under reduced pressure. The product was purified
by column chromatography (8:1 hexanes:EtOAc) yielding compound (CHS-4) (2.8 mg,
0.0005 mmol, 51%). 1H NMR (400 MHz, CDCl3) δ 7.99 (d, 1H, J = 16 Hz), 7.54 (s, 1H),
7.50 (s, 1H), 7.42 (d, 2H, J = 8 Hz), 7.09 (d, 2H, J = 8 Hz), 5.98 (d, 1H, J = 20 Hz), 5.01
(s, 1H), 4.95 (s, 2H), 3.25 (s, 3H), 3.06 (s, 1H), 2.19 – 0.88 (m, 20H).
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1.4.2 Chemiluminescent Response

The chemiluminescent response of CHS-5-AM with Emerald II Enhancer was done
with a Hitachi-7000 Fluorescence Spectrometer (Hitachi, Tokyo, Japan, Figure 5) using
the luminescence detection mode. 20 mM PBS buffer (pH 7.4), a 5 mM stock solution of
CHS-5-AM (final concentration of 20 μM), and a 50 mM stock solution of Na2S made
immediately before the experiment were used. For Figure 5, A, various percentages of
Emerald II Enhancer were used (0, 0.2, 2, 10%) with 1 mM Na2S. For Figure 5, B, 2%
enhancer was used with different concentrations of Na2S (0, 50, 100, 200, 400, 800, 1000
μM). After the addition of PBS buffer, the probe, Na2S, and the enhancer, the cuvette was
shaken gently and the time scans was performed seconds later. All experiments were
conducted at room temperature (25–28 °C) with three replicates of each.
The chemiluminescent response and time scans of CHS-4 and CHS-5-AM without
enhancer were obtained with a Cytation 5 Bio Tek plate reader (Winooski, VT, Figure 7)
using the luminescence detection method, endpoint read type with a gain set to 135, and
conducted at room temperature (25–28 °C). A 5mM stock solution of each probe was used
with a 20 μM final concentration. A 50 mM stock solution of Na2S was made on the day
of each experiment and the final concentration used varied (0, 50, 100, 200, 400, 800, 1000
μM). Experiments were performed in 20 mM PBS buffer (pH 7.4) in a multi-well plate.
Scans were ran immediately following the addition of PBS buffer, probe, and Na2S. Three
replicates of each were obtained.
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1.4.3 Cellular Experiments

Human lung adenocarcinoma epithelial cells (A549) were purchased from ATCC.
The cells were cultured in Ham’s F-12K (Kaighn’s) medium with 10% Fetal Bovine Serum
(FBS) and 1% antibiotics (penicillin/streptomycin, 100 U/mL). Cells were kept in a
humidified incubator at 37 °C with 5% CO2. One or two days before a cellular experiment
was conducted, cells were plated onto a sterile multi-well plate and allowed to reach a
confluence of 80–95% by the time of testing. All chemiluminescent responses for cellular
testing were obtained using the Cytation 5 Bio Tek plate reader (Winooski, VT) at 37 °C.
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APPENDIX

Cell Culture Protocol
Human lung adenocarcinoma epithelial cells (A549) were purchased from ATCC
and is the only current cell line in the lab. Cells are kept in a humidified incubator at
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°C with 5% CO2.
The cells are cultured in Ham’s F-12K (Kaighn’s) medium supplemented with 10%
Fetal Bovine Serum (FBS) and 1% antibiotics (penicillin/streptomycin, 100 U/mL). To
make complete F-12K medium for culturing A549 cells follow the following steps:
1. Turn on the UV for the hood 10 minutes prior to working in it.
2. Spray the hood down with the 70% alcohol mixture and wipe dry with paper
towel.
3. Put the following items in the hood (after warming them up in the 37 °C water
bath and then spraying with the alcohol mixture): a new bottle of incomplete F12K (500 mL), FBS, and the penicillin.
4. Take out 55 mL of the incomplete F-12K media using a 55 mL pipette and
transfer into a falcon tube. Label this falcon tube as “incomplete F-12K and the
date”.
5. Using another 55 mL pipette, add 50 mL of FBS to the remainder of the
incomplete F-12K bottle.
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6. Then using a 5 mL pipette, add 5 mL of penicillin to the incomplete F-12K
bottle.
7. Swirl gently to ensure mixing without causing bubbles.
8. Label the bottle as “Complete and date and ARL”. The mixture will be a red
color at first and then turn to a pink color over time.
9. Store the complete media in the fridge.
10. The FBS is stored in Dr. Zoltowski’s lab in the –80 °C freezer. Make 4 aliquots
of 50 mL FBS in falcon tubes to keep in the fridge before storing it the freezer.

To passage A549 cells, follow the following steps:
1. Check the confluence of the cells. The confluence should be around 80–95%
before passaging. Otherwise, wait another day or two to allow the cells to
proliferate more.
2. Turn on the UV for the hood 10 minutes prior to working in it.
3. Spray the hood down with the 70% alcohol mixture and wipe dry with paper
towel.
4. Put the following items in the hood (after warming them up in the 37 °C water
bath and then spraying with the alcohol mixture): the complete F-12K media,
trypsin, and PBS.
5. To start, remove the cell flask from the incubator and aspirate off the old media.
6. Wash away the dead cells by rinsing the cells with 10 mL of PBS (use a 10 mL
pipette). Then aspirate off the PBS.
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7. Add 2 mL of trypsin to the flask. Move the plate around to ensure all the cells
are coated with trypsin. Then incubate for 10 minutes to allow the trypsin to
break the bonds between the cell surface and the flask.
8. Then bring the flask back to the hood and add 10 mL of complete F-12K media.
Swirl the flask slightly to make sure all the cells are in the media.
9. Using the same 10 mL pipette, draw up the entire contents of the flask back into
the pipette and transfer into a falcon tube.
10. Tightly cap the flacon tube and put it into the centrifuge for 10 minutes at 1000
rpm.
11. Aspirate off the supernatant. Then add about 1 mL of complete media to the
falcon tube. Disperse the cells evenly throughout by using a 1000 μL pipette
and pipetting up and down multiple times.
12. Add 20 mL of complete F-12K media to a new T75 flask.
13. Add 20 μL of the cells to the flask and gently rock the flask back and forth to
disperse the cells. Check the confluence of the cells. If more cells are needed,
continue to add cells and check the confluence.
14. Lastly, label the flask with the your initials, the date, the cell line (A549), and
the passage and generation number. Store in the incubator.

The frozen cells are kept in a liquid nitrogen tank and a binder is kept nearby with the
inventory of the frozen cells. To freeze cells, follow the following steps:
1. Freezing more cells should be done after 2 or 3 passages from newly thawed
cells. This allows the cells to grow enough before freezing again.
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2. The confluence should be around 80–90 % before freezing.
3. Prepare 10 mL the freezing media (10% cell-culture grade DMSO in complete
media). This will make 10 vials for freezing.
4. Follow all cell passaging steps like normal up until the centrifuge step.
5. After the centrifuge step, aspirate off the media.
6. Add 1 mL of the cell freezing media. Disperse the cells throughout the media
by pipetting up and down with a 1000 μL pipette.
7. Then add the rest of the freezing media to the falcon tube and mix.
8. Use the cryopreservation vials to freeze the cells. Add 1 mL of the cell mixture
to each vial. Cap the vials tightly and label with the cell type, generation and
passage number, date, and initials. Parafilm the lids of the vials.
9. Put the vials in the Mr. Frosty vial container and put into the –80 °C freezer in
Dr. Zoltowski’s lab for 3 days.
10. After 3 days, transfer the vials into the liquid nitrogen container.
11. Fill out the cell inventory in the liquid nitrogen storage chart.

To thaw cells, follow the following steps:
1. Turn on the UV for at least 10 minutes prior to starting.
2. Put the complete F-12K media in the water bath and allow to reach 37 °C.
3. Check the inventory of the cells to locate the vials in the liquid nitrogen storage
chart. Pull up the cells from the liquid nitrogen tank- labeled as B. Let the liquid
nitrogen drip back into the tank before pulling it all the way out. Use the thick
orange gloves when handling the storage containers in the liquid nitrogen tank.
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4. Take out 2 vials and allow them to thaw on the counter for about 5–10 minutes.
5. Spray down the hood with the 70% alcohol spray.
6. In the hood, draw up the cells from the vials and transfer into a falcon tube.
7. Add complete F-12K media to the falcon tube so the total volume is about 10
mL.
8. Centrifuge for 10 minutes at 1000 rpm.
9. Then remove the media from the falcon tube, leaving the pellet of cells.
10. Add 1 mL of complete F-12K media to the falcon tube and pipette up and down
to mix.
11. Add about 20 mL of complete F-12K media to a new T75 flask.
12. Add ALL the cells from the falcon tube into the T flask.
13. Label the flask with your initials, the date, the cell line (A549), and the passage
and generation number. (If the cell vial thawed was labeled “P2G2”, then this
new flask would be labeled “P1G3”. Store the cells in the incubator.
14. The next day, remove the media and wash the cells with 10 mL PBS. Then
aspirate off the PBS and add 20 mL of complete F-12K media. The purpose of
this step is to remove the dead cells that did not survive the freezing and thawing
cycle.
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